CEO Executive AssistantThe Head of Clinical Development at a pharmaceutical company oversees the clinical programs that determine whether investigational drugs reach patients. Managing multiple concurrent clinical trials, regulatory meetings with FDA and global health authorities, relationships with clinical investigators and key opinion leaders, and oversight of clinical operations creates an administrative burden that can consume executive capacity unless well supported. A personal assistant helps the Head of Clinical Development focus on the scientific and strategic dimensions of clinical leadership.
The Head of Clinical Development Role
Clinical development heads are responsible for designing, executing, and overseeing clinical trials that generate the efficacy and safety evidence required for regulatory approval. This encompasses trial design, protocol development, regulatory strategy, investigator selection, data quality oversight, and interpretation of clinical results.
The role sits at the intersection of medicine, regulatory science, and business strategy. The clinical development head must think simultaneously about statistical rigor, patient safety, regulatory acceptability, and commercial relevance of the clinical program. External relationships with clinical investigators, regulatory authorities, patient advocacy groups, and data safety monitoring boards are all central to effective clinical leadership.
Core PA Responsibilities
Regulatory Meeting Preparation and Scheduling
FDA Type A, B, and C meetings, end-of-phase meetings, pre-BLA/NDA meetings, and international regulatory authority consultations are critical milestones in clinical development. The PA coordinates scheduling for regulatory interactions, manages meeting request documentation, and ensures the clinical development head is prepared with appropriate briefing materials.
Clinical Investigator and KOL Relationship Management
Principal investigators at major academic medical centers and clinical trial sites are central relationships for clinical development leadership. The PA manages scheduling for investigator meetings, advisory board sessions, and KOL scientific dinners at conferences, tracking relationship touchpoints and follow-up.
Clinical Trial Oversight Scheduling
DSMB meetings, steering committee calls, medical monitoring reviews, and internal clinical development team meetings all require consistent scheduling and coordination. The PA manages these recurring meeting structures, prepares materials, and tracks action items.
Conference Coordination
Clinical development heads present trial data and clinical strategy at major medical conferences. The PA manages conference scheduling, abstract submission logistics, and associated investor and partner meetings.
Patient Advocacy Engagement
Patient advocacy organizations are increasingly important partners in clinical development. The PA coordinates meetings with patient advocates, manages correspondence, and prepares briefing materials for patient community engagement.
Internal Cross-Functional Coordination
Clinical development intersects with regulatory affairs, medical affairs, biometrics, clinical operations, and commercial teams. The PA manages cross-functional meeting scheduling, tracks shared action items, and ensures the clinical development head has comprehensive preparation for cross-functional leadership discussions.
The Unique Demands of Clinical Development Leadership
Patient safety is the paramount responsibility in clinical development. Every clinical decision has potential patient welfare implications. The Head of Clinical Development must be reachable and briefed on safety developments as they arise. The PA should understand the urgency of safety-related communications and ensure they reach the executive immediately.
Data confidentiality is critical. Unblinded clinical trial data is among the most sensitive corporate information in pharmaceutical companies, with insider trading implications. The PA must understand and strictly observe data confidentiality protocols.
Global trial management adds complexity. Most pharmaceutical clinical programs involve investigator sites across multiple continents, requiring coordination across time zones and regulatory jurisdictions. The PA must be comfortable managing international scheduling and communications.
McKinsey has analyzed clinical development productivity extensively, noting that executive engagement quality with regulatory authorities and clinical investigators is a primary driver of trial success and approval timelines.
How to Hire for This Role
Seek Clinical Research or Pharmaceutical Experience
Candidates with prior experience in clinical research organizations, pharmaceutical clinical operations, or academic clinical research will understand the regulatory environment, clinical trial culture, and patient safety priorities that define this role.
Assess Regulatory Process Familiarity
Basic understanding of IND regulations, FDA meeting types, and the clinical development timeline is important. Candidates who can accurately describe the clinical development process, even at a general level, will ramp up faster.
Evaluate Attention to Detail
Clinical development involves detailed documentation, precise data management, and accurate regulatory communications. The PA must demonstrate exceptional attention to detail. Request examples of complex scheduling or documentation management from previous roles.
Test Communication Quality
The PA will draft correspondence to regulatory authorities, clinical investigators, and patient advocates. Request writing samples that demonstrate precision, clarity, and appropriate professional tone.
Compensation and Costs
Personal assistants for pharmaceutical heads of clinical development typically earn between $70,000 and $105,000 annually. Large pharmaceutical companies or those with multiple active clinical programs tend to pay at the higher end. Comprehensive benefits and performance bonuses are standard.
The Value Delivered
Regulatory meeting management is particularly high leverage for clinical development leaders. The quality and thoroughness of FDA meeting preparations directly affects the quality of regulatory interactions that shape clinical program strategy. A PA who helps ensure comprehensive preparation for every regulatory meeting produces better regulatory outcomes.
Pharma executive administrative support covers the broader landscape of executive support across pharmaceutical development roles.
Clinical investigator relationship management is equally important. Principal investigators at leading academic medical centers are a limited and highly sought-after resource. Consistent, respectful engagement from clinical development leadership is a differentiating factor in investigator participation decisions.
Building the Partnership
The PA should develop familiarity with the company’s clinical pipeline, the regulatory calendar for active programs, and the key investigator and KOL relationships during onboarding. Clear protocols for handling safety-related communications, regulatory correspondence, and conference scheduling decisions are particularly important to establish early.
Personal assistant support in pharmaceutical development provides additional context on administrative support across pharmaceutical development workflows.
Conclusion
The pharmaceutical Head of Clinical Development carries one of the most scientifically and operationally complex leadership roles in the industry. Managing a multi-program clinical portfolio while maintaining regulatory credibility, investigator relationships, and patient safety oversight requires both exceptional scientific judgment and strong administrative support.
A personal assistant who understands the clinical development environment and provides precise, discreet, and substantive support enables the clinical development head to lead with the focus and credibility that this critical role demands.
Related Reading
For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.